Showing results (31-40 of 150) with videos related to
Sort By:
Pageof 15
Frontiers in Aging Neuroscience|August 9, 2017
Microglia Responses in Acute and Chronic Neurological Diseases: What Microglia-Specific Transcriptomic Studies Taught (and did Not Teach) UsHélène E Hirbec, Harun N Noristani, Florence E PerrinMedical & Biological Engineering & Computing|July 1, 1997
Acoustical recognition of laryngeal pathology using the fundamental frequency and the first three formants of vowelsE Perrin, C Berger-Vachon, I Kauffmann, et al.American Journal of Medical Genetics|October 1, 1982
A lethal, Larsen-like multiple joint dislocation syndromeH Chen, C H Chang, E Perrin, et al.Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1979
[Methods of tissue characterization with ultrasonic spectroscopy, analysis of the results obtained, prospects for clinical application in a short time]J E Perrin, G Berger, A Salesses, et al.Journal of Pediatric Gastroenterology and Nutrition|November 1, 1987
Renal abnormalities in paucity of interlobular bile ductsV Tolia, R S Dubois, F B Watts, et al.International Journal of Peptide and Protein Research|August 1, 1995
Determination of the ratios of the aromatic amino acid residues by first- or second-derivative UV spectrometry for a simple characterization of peptidesL Miclo, E Perrin, A Driou, et al.Journal of Neurochemistry|July 13, 2006
Cell death pathways differ in several mouse models with motoneurone disease: analysis of pure motoneurone populations at a presymptomatic ageFlorence E Perrin, Gaelle Boisset, Aurélien Lathuilière, et al.Brain : a Journal of Neurology|February 4, 2005
Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degenerationFlorence E Perrin, Steve Lacroix, Marcelino Avilés-Trigueros, et al.L'Encephale|April 11, 2001
[Determinants of compliance with antidepressive drugs]I Gasquet, J Bloch, B Cazeneuve, et al.Acta Psychiatrica Scandinavica|October 7, 2006
The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trialY Lecrubier, P Quintin, M Bouhassira, et al.Pageof 15